1.Plasma BNP levels and serum albumin, serum total bilirubin and prothrombin time in patients with cirrhosis correlation
Qunhong SHEN ; Jinghui CHU ; Mengli LUO ; Jianbo ZHOU
Chinese Journal of Biochemical Pharmaceutics 2017;37(2):288-290
Objective To investigate the correlation of plasma brain natriuretic peptide (BNP) level with serum albumin, serum total bilirubin and thrombin time in patients with liver cirrhosis.Methods RandomLy selected from January 2014 to June 2016 to our hospital diagnosis and hospitalization of 200 cases of cirrhosis patients, according to the standard of Child-Pugh classification provided by Chinese Medical Hepatology Division in 2006, 48 cases were Child A group, 96 cases were Child B group and 56 cases were Child C group.The plasma BNP, serum albumin, serum total bilirubin, prothrombin time and QTc interval of electrocardiogram were analyzed in the clinical data of each group of patients and the correlation between plasma BNP and their correlation.Results The levels of plasma BNP in Child A, B and C groups were higher than those in B group and B group.The correlation between plasma BNP and Child's grade showed a positive correlation, and the results of each group were statistically different (P<0.05).The plasma BNP level was negatively correlated with ALB ( P<0.05 ) .The level of plasma BNP was positively correlated with ALB ( P <0.05 ) .The correlation between plasma BNP and PTIL was correlated with TBIL.The correlation between plasma BNP and TBIL was significantly correlated with TBIL ( P <0.05), The higher the plasma BNP, the regression analysis showed that plasma BNP and TBIL were positively correlated, the difference was statistically significant (P<0.05).The correlation between plasma BNP level and QTc was analyzed.The QTc interval of plasma BNP level was higher than that of the control group ( P<0.01 ) , and the difference was statistically significant ( P <0.01 ) .Conclusion The plasma BNP level in patients with liver function is closely related to ALB, TBIL, PT, QTc interval, and has the value of evaluating and predicting liver function.
2. Chronopharmacokinetics research of helicid and its metabolites
Yuanwei JIA ; Jie SHEN ; Haitang XIE ; Bin YANG ; Xianghong LI ; Jiru CHU ; Dandan ZHENG ; Cuifeng ZHANG ; Jinghui ZHAO
Chinese Journal of Clinical Pharmacology and Therapeutics 2021;26(9):986-994
AIM: To study chronopharmacokinetics of helicid and its metabolites. METHODS: An HPLC-MS method for simultaneous determination of helicid and its three phase I metabolites were established and validated. At 8:00, 14:00 and 0:00, the rats were given helicid 50 mg/kg by gavage, respectively. Blood samples were collected from ophthalmic venous plexus. Then plasma concentration was measured. Pharmacokinetic behaviors of the original drug and its metabolites after administration at different time points were calculated and compared. RESULTS: This established HPLC-MS/MS method was successfully applied to simultaneous determination of helicid and its three metabolites in rat plasma after intragastric administration. Using AUC
3.FOXO3-engineered human mesenchymal progenitor cells efficiently promote cardiac repair after myocardial infarction.
Jinghui LEI ; Si WANG ; Wang KANG ; Qun CHU ; Zunpeng LIU ; Liang SUN ; Yun JI ; Concepcion Rodriguez ESTEBAN ; Yan YAO ; Juan Carlos Izpisua BELMONTE ; Piu CHAN ; Guang-Hui LIU ; Weiqi ZHANG ; Moshi SONG ; Jing QU
Protein & Cell 2021;12(2):145-151